Circular RNAs (circRNAs) are a class of noncoding RNAs that are widely expressed in cancer tissues and play a pro- or anticancer role in modulating cancer progression. This work is aimed to probe the biological role of circ_0000317 in colorectal cancer (CRC) and its underlying mechanism. Circ_0000317 was selected from the circRNA microarray datasets (GSE121895). Quantitative real-time polymerase chain reaction was utilized to examine circ_0000317, microRNA (miR)-520g, and homeobox D10 (HOXD10) mRNA expression in CRC. Cell Counting Kit-8 and Transwell experiments were conducted to examine the effects of circ_0000317 on proliferation, migration, and invasion of CRC cells. Bioinformatic analysis and dual-luciferase reporter gene experiments were implemented to predict and validate the targeting relationship between circ_0000317 and miR-520g, miR-520g, and HOXD10. Western blot was employed to examine HOXD10 expression at protein level in CRC cells. Circ_0000317 and HOXD10 mRNA expression were unveiled to be down-modulated and miR-520g expression was up-modulated in CRC. Functionally, circ_0000317 overexpression repressed CRC cell proliferation, migration, and invasion. Mechanistically, miR-520g was a direct target of circ_0000317 and miR-520g specifically modulated HOXD10 expression. Furthermore, miR-520g mimics partially counteracted the suppressing effect of circ_0000317 on malignant phenotype of CRC cells. Circ_0000317 represses CRC progression by targeting miR-520g and modulating HOXD10 expression. Hence, circ_0000317 may be a promising diagnostic biomarker and a therapeutic target for CRC.
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):118-126
[PMID:
29364478]
Oncol Rep. 2015 Oct;34(4):1681-91
[PMID:
26260613]
Lancet. 2019 Oct 19;394(10207):1467-1480
[PMID:
31631858]
Neurosurg Rev. 2020 Jun;43(3):903-910
[PMID:
30788677]
J Cell Physiol. 2019 Aug;234(8):12369-12384
[PMID:
30605237]
Nutrients. 2019 Jan 14;11(1):
[PMID:
30646512]
Clin Epigenetics. 2017 Oct 23;9:116
[PMID:
29075359]
Cell Commun Signal. 2019 Jan 25;17(1):9
[PMID:
30683109]
Cancer Cell Int. 2017 Oct 28;17:91
[PMID:
29118671]
Cancer Discov. 2013 Oct;3(10):1113-21
[PMID:
24072616]
Onco Targets Ther. 2016 Dec 09;9:7451-7458
[PMID:
28003761]
Med Sci Monit. 2018 Dec 19;24:9232-9239
[PMID:
30565566]
Nat Rev Genet. 2019 Nov;20(11):675-691
[PMID:
31395983]
CA Cancer J Clin. 2020 May;70(3):145-164
[PMID:
32133645]
Biochem Biophys Res Commun. 2018 Feb 26;497(1):122-126
[PMID:
29421663]
J Mol Med (Berl). 2014 Aug;92(8):811-23
[PMID:
24996520]
FEBS Lett. 2015 Jan 2;589(1):102-9
[PMID:
25436421]
Kaohsiung J Med Sci. 2021 Nov;37(11):951-963
[PMID:
34292663]
Nature. 2014 Jan 16;505(7483):344-52
[PMID:
24429633]
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
[PMID:
28209991]
Mol Cancer. 2020 Jan 23;19(1):13
[PMID:
31973707]
Life Sci. 2020 Aug 1;254:117176
[PMID:
31843532]
J Exp Clin Cancer Res. 2018 Dec 27;37(1):325
[PMID:
30591054]
Onco Targets Ther. 2019 Nov 27;12:10275-10285
[PMID:
31819512]
Signal Transduct Target Ther. 2018 Dec 28;3:33
[PMID:
30603114]
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7371-7378
[PMID:
30468483]
J Cell Physiol. 2019 May;234(5):7247-7256
[PMID:
30370521]
Nat Rev Cancer. 2010 May;10(5):361-71
[PMID:
20357775]
Oncol Rep. 2017 Jun;37(6):3415-3422
[PMID:
28498456]
Int J Clin Exp Pathol. 2018 Mar 01;11(3):1399-1406
[PMID:
31938236]
Cell Cycle. 2019 Jul;18(14):1660-1669
[PMID:
31204563]
Cancer Manag Res. 2019 Jun 06;11:5317-5332
[PMID:
31239781]
Am J Transl Res. 2019 Apr 15;11(4):2439-2446
[PMID:
31105850]
Biomed Pharmacother. 2017 Nov;95:1314-1320
[PMID:
28938522]
Pharmacol Ther. 2018 Jul;187:31-44
[PMID:
29406246]
J Cell Physiol. 2019 May;234(5):5451-5465
[PMID:
30471116]
World J Surg Oncol. 2015 Aug 28;13:259
[PMID:
26311318]
Oncol Lett. 2018 May;15(5):7069-7075
[PMID:
29731873]
Eur Rev Med Pharmacol Sci. 2016;20(4):657-63
[PMID:
26957267]
